The feasibility of harmonizing health technology assessments across jurisdictions: A case study of drug eluting stents

International Journal of Technology Assessment in Health Care

Volumn 25, Issue 4, 2009, Pages 455-462

  Trueman, Paul ^a   Hurry, Manjusha ^a   Bending, Matthew ^a   Hutton, John ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Drug eluting stents; Harmonization; Health technology assessment

Indexed keywords

DATA SETS; DRUG-ELUTING STENTS; HEALTH TECHNOLOGY ASSESSMENTS; HTA METHODS;

HEALTH; RESEARCH; TECHNOLOGY;

TECHNOLOGICAL FORECASTING;

DEXAMETHASONE; PACLITAXEL; RAPAMYCIN;

ARTICLE; BARE METAL STENT; BIOMEDICAL TECHNOLOGY ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG ELUTING STENT; ECONOMIC EVALUATION; HEALTH CARE COST; HUMAN; MEDICAL INFORMATION; STENT THROMBOSIS; SYSTEMATIC REVIEW; COST BENEFIT ANALYSIS; INTERNATIONAL COOPERATION; METHODOLOGY; ORGANIZATION AND MANAGEMENT; OUTCOME ASSESSMENT; REGISTER; STANDARD;

CLINICAL TRIALS AS TOPIC; COST-BENEFIT ANALYSIS; DRUG-ELUTING STENTS; HUMANS; INTERNATIONAL COOPERATION; OUTCOME ASSESSMENT (HEALTH CARE); REGISTRIES; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 74049104553     PISSN: 02664623     EISSN: 14716348     Source Type: Journal    
DOI: 10.1017/S0266462309990389     Document Type: Article

References (16)

1. Banta D. The development of health technology assessment. Health Policy. 2003;63:121-132.
2. Bowen J, Hopkins R, He Y, et al. Systematic review and cost effectiveness analysis of drug eluting stents compared to bare metal stents for percutaneous coronary interventions in Ontario. Final Report. PATH Research Institute; May 2007.
3. Busse R, Orvain J,VelascoM, et al. Best practice in undertaking and reporting Health Technology Assessments. Int J Technol Assess Health Care. 2002;18:361-422.
4. Centre for Reviews & Dissemination. Systematic reviews: CRD's guidance for undertaking reviews in healthcare. University of York, United Kingdom: Centre for Reviews & Dissemination; January 2009.
5. Core HTA. Drug eluting stents. European Network for Health Technology Assessment, work package 4, draft report, July 2007. http://www.eunethta.net/ upload/WP4/EUnetHTA- WP4-CoreHTAonDES-FirstPublicDraftRevised-2007-07-11.pdf (accessed on April 22, 2009).
6. Cranovsky R, Matillion Y, Banta HD. EUR-ASSESS project subgroup on coverage. Int. J Technol Assess Health Care. 1997;13:287-332.
7. Culyer AJ, Lomas J. Deliberative processes and evidenceinformed decision-making in health care: do they work and how might we know? Evid Policy. 2006;2:357-371.
8. Hill R, Boland A, Dickson R, et al. Drug eluting stents: A systematic review and economic evaluation. Health Technol Assess. 2007;11:iii, xi-221.
9. HTA Core Model for Medical and Surgical Interventions. European Network for Health Technology Assessment, work package 4, draft report, July 2007. http://www.eunethta.net/ upload/WP4/EUnetHTA-WP4-CoreModelforInterventions- FirstPublicDraftRevised-2007-07-11.pdf (accessed on April 22, 2009).
10. EUnetHTA: European Network for Health Technology Assessment. http://www.eunethta.net/Home/ (accessed April 21, 2009).
11. Hutton J, Trueman P, Facey K. Harmonisation of evidence requirements for health technology assessment in reimbursement decision making. Int J Technol Assess Health Care. 2008;24:511-517.
12. Jonsson E, Banta HD, Henshall C, Sampietro-Colom L. Summary report of the ECHTA/ECAHI project. European Collaboration for HealthTechnology Assessment/Assessment of Health Interventions. Int J Technol Assess Health Care. 2002;18:218-237.
13. Kvas E. Drug eluting stents in comparison to uncoated stents in the treatment of cardiopathy. Rapid Assessment. LBI-HTA 01, 2006.
14. Ong AT, McFadden EP, Regar E, et al. Late angiographic stent thrombosis (LAST) events with drug eluting stents. J Am Coll Cardiol. 2005;45:2088-2092.
15. Vinck I, NeytM, Thiry N, et al. Drug eluting stents in Belgium. Health technology assessment. Belgian Healthcare Knowledge Centre (KCE); 2007.
16. Weinstein MC, O'Brien B, Hornberger J, et al. Principles of good practice for decision analytic modelling in health care evaluation: Report of the ISPOR task force on good research practices -modelling studies. Value Health. 2003;6:9-17.